Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mithramycin derivatives having increased selectivity and anti-cancer activity

Mithramycin derivatives having increased selectivity and anti-cancer activity

US Patent 11224609 · Granted Jan 18, 2022

Estimated economic value: $13,188,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mithramycin oxime derivatives having increased selectivity and anti-cancer activ2025
Mithramycin oxime derivatives having increased selectivity and anti-cancer activ2025
Mithramycin oxime derivatives having increased selectivity and anti-cancer activ2025
Mithramycin derivatives having increased selectivity and anti-cancer activity2023
Mithramycin derivatives having increased selectivity and anti-cancer activity2023
Mithramycin derivatives having increased selectivity and anti-cancer activity2023
Mithramycin derivatives having increased selectivity and anti-cancer activity2023
Mithramycin derivatives having increased selectivity and anti-cancer activity2023
Mithramycin derivatives having increased selectivity and anti-cancer activity2023
Mithramycin derivatives having increased selectivity and anti-cancer activity2023
Mithramycin oxime derivatives having increased selectivity and anti-cancer activ2022
Mithramycin oxime derivatives having increased selectivity and anti-cancer activ2022